The year 2020 might bear witness to a significant shift in control of health care from the providers, insurers, and the government to actual health care consumers. First, it was the politicians, then the tech conferences and promises of 5G, and now global pandemic scares are all signaling the demand for remote health care. The delivery of health care has been in the hands of hospitals and physicians for nearly a century. The government really started to exert their control when Medicare and Medicaid started in the 1960s. Large private insurance companies started to significantly exert their control in the 1970s. With the coming of Obamacare almost exactly a decade ago, the structure of health plans changed as their profit model counted on greater patient responsibility through high deductible and copays. The failure of hospitals, physicians, pharmaceutical companies, and insurance companies to be able to work together has caused consolidation. Either as a cause or result of the consolidation, investors’ payback demands and greed have further exploded health care pricing. This past decade saw pharmaceutical companies and pharmacies dramatically raise their prices on common medications. One example was a commonly prescribed antibiotic that went from $4 to in excess of $600 for the same medication. Many hospitals and some physicians have similarly raised their prices but not to those extremes. Insurance companies have also posted record profits with no intentions of slowing down. As a result, U.S. employers large and small are losing their competitive advantage in an international economy, and U.S. patients are either foregoing health care or facing bankruptcy as even insured patients are realizing that their insurance is “subprime” and inadequate to cover their needs. As a result, Congress and the Senate have proposed legislation that will essentially “rate set” some of the physician and pharmaceutical charges. Unfortunately, they have not realized or don’t have the political will to deal with the real problem, which is health plan design, and investor domination of insurance companies, pharmaceutical companies, and hospitals, and now practitioner organizations. However, as Congress and the Senate try to dance around and try to find temporary solutions to the insurance design crisis, some of our largest and innovative companies are somewhat silently creating a shift in health care delivery. I think the signal occurred less than two years ago on January 30, 2018, when Amazon, Berkshire Hathaway, and J.P. Morgan announced the formation of the nonprofit Haven. More recently, Apple’s health care market opportunity was estimated to be as high as a whopping $313 billion in revenue by 2027, according to estimates from a team of Morgan Stanley analysts. Apple has gone one step further and created a subsidiary called AC Wellness. Google is in the game as well with Verily Life Sciences. Not to be outdone, even small retail companies like Best Buy are entering the marketplace, and virtually every large direct to consumer retail company has entered the arena, including CVS, Walgreens, Target, Walmart, and Kroger. The enabling pieces are also being put together. On October 30, 2019, both the Congress and Senate announced bipartisan, bicameral legislation to finally empower telehealth and telemedicine and on December 31, 2019, the American Medical Association announced its call to support the Interstate Medical Licensure Compact so that physicians can use telehealth to compete against vendors, retail clinics and payers moving into the space. All of this is signaling the same thing. The industry resistance to change is over. Telehealth is the future, and the future is imminent. The next several years will likely finally see a dramatic increase in the use of telehealth to improve health care delivery and decrease costs. This will likely decrease the delays in seeing a specialist, expand rural access to health care, and decrease the need for medical transport to hospitals and often times physician’s offices. With every change, there will be winners and losers, and there still will likely be resistance by those unable or unwilling to change. Likely this time, patient’s access to care will be faster, the care better, and the cost lower. Paul D. Kivela is an emergency physician and CMO, ConveneMed. Source
